-->
1 PREFACE
2 SCOPE AND METHODOLOGY
2.1 OBJECTIVES OF THE STUDY
2.2 STAKEHOLDERS
2.3 DATA SOURCES
2.3.1 PRIMARY SOURCES
2.3.2 SECONDARY SOURCES
2.4 MARKET ESTIMATION
2.4.1 BOTTOM-UP APPROACH
2.4.2 TOP-DOWN APPROACH
2.5 FORECASTING METHODOLOGY
3 EXECUTIVE SUMMARY
4 JAPAN CLINICAL NUTRITION FOR DIABETES CARE MARKET - INTRODUCTION
4.1 OVERVIEW
4.2 MARKET DYNAMICS
4.3 INDUSTRY TRENDS
4.4 COMPETITIVE INTELLIGENCE
5 JAPAN CLINICAL NUTRITION FOR DIABETES CARE MARKET LANDSCAPE
5.1 HISTORICAL AND CURRENT MARKET TRENDS
5.2 MARKET FORECAST (2025-2033)
6 JAPAN CLINICAL NUTRITION FOR DIABETES CARE MARKET - BY PRODUCT
6.1 ORAL NUTRITION
6.1.1 OVERVIEW
6.1.2 HISTORICAL AND CURRENT MARKET TRENDS
6.1.3 MARKET FORECAST (2025-2033)
6.2 PARENTERAL NUTRITION
6.2.1 OVERVIEW
6.2.2 HISTORICAL AND CURRENT MARKET TRENDS
6.2.3 MARKET FORECAST (2025-2033)
6.3 ENTERAL FEEDBACK FORMULAS
6.3.1 OVERVIEW
6.3.2 HISTORICAL AND CURRENT MARKET TRENDS
6.3.3 MARKET FORECAST (2025-2033)
7 JAPAN CLINICAL NUTRITION FOR DIABETES CARE MARKET - BY STAGE
7.1 ADULT
7.1.1 OVERVIEW
7.1.2 HISTORICAL AND CURRENT MARKET TRENDS
7.1.3 MARKET FORECAST (2025-2033)
7.2 PEDIATRIC
7.2.1 OVERVIEW
7.2.2 HISTORICAL AND CURRENT MARKET TRENDS
7.2.3 MARKET FORECAST (2025-2033)
8 JAPAN CLINICAL NUTRITION FOR DIABETES CARE MARKET – BY DISTRIBUTION CHANNEL
8.1 ONLINE
8.1.1 OVERVIEW
8.1.2 HISTORICAL AND CURRENT MARKET TRENDS
8.1.6 MARKET FORECAST (2025-2033)
8.2 RETAIL
8.2.1 OVERVIEW
8.2.2 HISTORICAL AND CURRENT MARKET TRENDS
8.2.6 MARKET FORECAST (2025-2033)
8.3 INSTITUTIONAL SALES
8.3.1 OVERVIEW
8.3.2 HISTORICAL AND CURRENT MARKET TRENDS
8.3.6 MARKET FORECAST (2025-2033)
9 JAPAN CLINICAL NUTRITION FOR DIABETES CARE MARKET – COMPETITIVE LANDSCAPE
9.1 OVERVIEW
9.2 MARKET STRUCTURE
9.3 MARKET PLAYER POSITIONING
9.4 TOP WINNING STRATEGIES
9.5 COMPETITIVE DASHBOARD
9.6 COMPANY EVALUATION QUADRANT
10 PROFILES OF KEY PLAYERS
10.1 ABBOTT JAPAN
10.1.1 BUSINESS OVERVIEW
10.1.2 SERVICES OFFERED
10.1.3 BUSINESS STRATEGIES
10.1.4 SWOT ANALYSIS
10.1.5 MAJOR NEWS AND EVENTS
10.2 EISAI CO. LTD
10.2.1 BUSINESS OVERVIEW
10.2.2 SERVICES OFFERED
10.2.3 BUSINESS STRATEGIES
10.2.4 SWOT ANALYSIS
10.2.5 MAJOR NEWS AND EVENTS
10.3 OTSUKA PHARMACEUTICAL CO. LTD
10.3.1 BUSINESS OVERVIEW
10.3.2 SERVICES OFFERED
10.3.3 BUSINESS STRATEGIES
10.3.4 SWOT ANALYSIS
10.3.5 MAJOR NEWS AND EVENTS
10.4 NESTLÉ JAPAN
10.4.1 BUSINESS OVERVIEW
10.4.2 SERVICES OFFERED
10.4.3 BUSINESS STRATEGIES
10.4.4 SWOT ANALYSIS
10.4.5 MAJOR NEWS AND EVENTS
10.5 DEXCOM
10.5.1 BUSINESS OVERVIEW
10.5.2 SERVICES OFFERED
10.5.3 BUSINESS STRATEGIES
10.5.4 SWOT ANALYSIS
10.5.5 MAJOR NEWS AND EVENTS
10.6 ELI LILY
10.6.1 BUSINESS OVERVIEW
10.6.2 SERVICES OFFERED
10.6.3 BUSINESS STRATEGIES
10.6.4 SWOT ANALYSIS
10.6.5 MAJOR NEWS AND EVENTS
10.7 SANOFI
10.7.1 BUSINESS OVERVIEW
10.7.2 SERVICES OFFERED
10.7.3 BUSINESS STRATEGIES
10.7.4 SWOT ANALYSIS
10.7.5 MAJOR NEWS AND EVENTS
10.8 ASCENSIA DIABETES CARE
10.8.1 BUSINESS OVERVIEW
10.8.2 SERVICES OFFERED
10.8.3 BUSINESS STRATEGIES
10.8.4 SWOT ANALYSIS
10.8.5 MAJOR NEWS AND EVENTS
10.9 ROCHE HOLDINGS AG
10.9.1 BUSINESS OVERVIEW
10.9.2 SERVICES OFFERED
10.9.3 BUSINESS STRATEGIES
10.9.4 SWOT ANALYSIS
10.9.5 MAJOR NEWS AND EVENTS
10.10 ARKAY INC.
10.10.1 BUSINESS OVERVIEW
10.10.2 SERVICES OFFERED
10.10.3 BUSINESS STRATEGIES
10.10.4 SWOT ANALYSIS
10.10.5 MAJOR NEWS AND EVENTS
11 JAPAN CLINICAL NUTRITION FOR DIABETES CARE MARKET - INDUSTRY ANALYSIS
11.1 DRIVERS, RESTRAINTS, AND OPPORTUNITIES
11.1.1 OVERVIEW
11.1.2 DRIVERS
11.1.3 RESTRAINTS
11.1.4 OPPORTUNITIES
11.2 PORTERS FIVE FORCES ANALYSIS
11.2.1 OVERVIEW
11.2.2 BARGAINING POWER OF BUYERS
11.2.3 BARGAINING POWER OF SUPPLIERS
11.2.4 DEGREE OF COMPETITION
11.2.5 THREAT OF NEW ENTRANTS
11.2.6 THREAT OF SUBSTITUTES
11.3 VALUE CHAIN ANALYSIS
12 APPENDIX
著作権 ©2022 無断複写・転載を禁じます